Coastlands Capital LP

Coastlands Capital LP buys 25,000 shares of ADIL at $2.60; stock down 84.9% from 52-week high but up 69.2% in 90 days.

Coastlands Capital LP, a 10% owner, purchased 25,000 shares at $2.60 on 2026-06-29, increasing holdings by 7.2% to 373,322 shares. The transaction occurs with the stock trading at $2.86, substantially below the 52-week high of $18.90 but up 69.2% over 90 days, indicating recent recovery momentum after severe depreciation. ADIAL Pharmaceuticals reported a negative net income of $-2.0M and has a market capitalization of $6.1M, reflecting financial stress and extreme micro-cap status. The insider's track record shows only 1 prior buy across all tickers, providing limited context for interpreting whether this represents a sustained conviction pattern or an isolated opportunistic entry at current price levels.

10% owner Coastlands Capital LP buys 100,000 shares of KTTA at $0.53; stock down 74.8% from 52-week high amid unprofitability.

Coastlands Capital LP, a 10% shareholder, purchased 100,000 shares at $0.53 on 2026-06-17, expanding its position from 3,735,035 to 3,835,035 shares. The transaction occurred as KTTA trades at $0.52, down 74.8% from its 52-week high of $2.06 and down 25.7% over the prior 30 days. The company is unprofitable with a net income of $-2.9M against quarterly revenue of only $218.6K, and a market cap of $17.4M. This buy-in from an existing 10% owner during sharply depressed trading and sustained loss-making conditions merits monitoring, as it may indicate near-term confidence in a turnaround, though the absence of material operational improvements or guidance changes in the filing limits the evidentiary weight of this single transaction.